To determine if intra-tumoral administration of AAV–IL-27 altered the tumor immune microenvironment, we examined the cellular components of tumor-infiltrating leukocytes in tumors from AAV–IL-27 or AAV-ctrl virus–treated mice using flow cytometry. The gene discussed is IL27; the disease is neoplasm.